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Background:  Myeloid-related protein (MRP)-8/14 is expressed by inflammatory cells and platelets in acute MI. Higher levels indicate increased 
risk for cardiovascular (CV) events in apparently healthy people and in patients post ACS. Data on the prognostic value of MRP-8/14 in stable 
coronary artery disease (CAD) are lacking.
Methods:  Circulating MRP-8/14 levels were measured (Buhlmann) in a nested case-cohort study of 977 patients with stable CAD from the PEACE 
trial. Levels between patients with and w/o CV death, MI or UA over a median of 4.8 y were compared using Wilcoxon rank sum test and risk across 
MRP-8/14 quartiles assessed using multivariable Cox proportional hazards modeling.
Results:  Higher MRP-8/14 levels were associated with diabetes and reduced eGFR. MRP-8/14 levels were significantly higher in patients who 
subsequently experienced CV death, MI or UA than in those who did not (median 3.42 mg/L [IQR 2.35, 4.96] vs 3.125 mg/L [2.09, 4.63], P=0.003). 
In quartile analysis, higher levels of MRP-8/14 were associated with an increased risk of CV death, MI or UA (P=0.002; HR 1.56 [1.07-2.24] for 
Q4 vs Q1). After adjustment for baseline clinical characteristics and the inflammatory biomarkers hs-CRP and Lp-PLA2, MRP-8/14 remained an 
independent predictor of CV death, MI, or UA (P=0.02).
Conclusions:  MRP-8/14 is an independent prognostic indicator of future coronary events in patients with stable CAD. These data justify further 
studies in larger cohorts and comparisons to other emerging biomarkers.
